focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBYOT.L Share News (BYOT)

  • There is currently no data for BYOT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Byotrol revenue and profit fall due to pandemic and Brexit woes

Wed, 08th Dec 2021 14:46

(Alliance News) - Byotrol PLC on Wednesday reported a sharp decline in interim revenue and profit, which resulted in a fall in its share price.

Shares in the infection prevention and control company were down 16% at 4.22 pence each on Wednesday afternoon in London.

The Manchester, England based firm recorded a pretax loss of GBP141,000 in the six months to September 30, swinging from a profit of GBP1.0 million a year before.

This was a consequence of interim revenue falling to GBP3.2 million, more than halved from the GBP6.7 million recorded a year prior.

The company explained this with the first half of the year being a challenge for product sales due to unexpectedly extended lockdowns, office closures and pricing pressures.

Brexit also presented a challenge, because it increased the amount of administration required to sell the company's product in the EU.

Moreover, the UK government decided to move away from a lot of the EU's regulatory regime on chemicals. This led to the company having to re-do regulatory approvals for the UK, based on a new, slightly different to expectations, regime.

Additionally, the company noted that half-year revenue and profit showed that it is "substantially" underinvested in consumer product sales. It is now taking steps to address this.

Byotrol also expressed concerns about the potential negative impact of full and partial lockdowns on the demand for consumables in the future.

Especially, due to the current uncertainty introduced by the new Omicron variant of Covid.

Nonetheless, the company still said it expects to be both profitable and cash generative in the second half of the year and maintained it is highly confident in medium and long-term growth.

"The group remains substantially ahead of the pre-Covid period in sales and profits and we expect that performance to endure," Non-Executive Chair John Langlands said.

By Abby Amoakuh; abbyamoakuh@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
21 Dec 2009 12:00

London midday: Oil fired Footsie

Oil is fuelling the Footsie's rise today, with support from back-in-favour banks. Cairn Energy has secured a drill ship to get an early start on its exploration activities in Greenland. The oil company said drilling in Greenland will start a year ahead of schedule after it came to a deal with Hess

Read more
21 Dec 2009 08:59

US patent boosts Byotrol

Germ killing technology company Byotrol's share price received a boost after it said that it had its US patent application accepted. Byotrol, which applied for the patent in 2002, said the patent runs until 2022. Meanwhile, a Fortune 150 multinational company has paid Byotrol and its joint ventur

Read more
20 Nov 2009 17:28

Jorge Cosmen raises National Express stake

Shares in National Express raced ahead after deputy chairman Jorge Cosmen increased his family's influence over the company, spending more than £1.7m on shares in the train and bus operator. He bought just over 500,000 shares at 341p a time and now has about 29m, which is just shy of 20% of the com

Read more
17 Nov 2009 14:37

Byotrol's bumper interim revenues

Anti-microbial technology developer Byotrol reported strong revenue growth in the six months to September 2009 but this rate of growth will be difficult to maintain. Revenues jumped from £388,000 to £2m - more than double the level for the previous 12 months. Publicity about swine flu and other in

Read more
17 Sep 2009 08:39

Small caps round-up: Byotrol, ReNeuron, Accuma...

Germ-killing product supplier Byotrol said it has seen a significant increase in orders and now expects results for the financial year to September 30 to be ahead of expectations. Shares in Meridian Petroleum gushed higher after the oil and gas firm announced an increase in prospective resources in

Read more
16 Jun 2009 14:18

Kugler appointed chairman at Byotrol

Germ killing product developer Byotrol saw losses widen and sales slide slightly last year but said the current outlook is promising, as test results demonstrate the effectiveness of its hygiene technology. Revenue in the year to 31 March 2009 eased to £0.93m from £0.95m the year before, while loss

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.